全文获取类型
收费全文 | 109155篇 |
免费 | 6515篇 |
国内免费 | 751篇 |
专业分类
耳鼻咽喉 | 1157篇 |
儿科学 | 2594篇 |
妇产科学 | 1759篇 |
基础医学 | 14960篇 |
口腔科学 | 1494篇 |
临床医学 | 9643篇 |
内科学 | 23400篇 |
皮肤病学 | 1531篇 |
神经病学 | 9726篇 |
特种医学 | 4389篇 |
外国民族医学 | 16篇 |
外科学 | 15698篇 |
综合类 | 3730篇 |
现状与发展 | 1篇 |
一般理论 | 97篇 |
预防医学 | 7834篇 |
眼科学 | 1863篇 |
药学 | 7436篇 |
34篇 | |
中国医学 | 727篇 |
肿瘤学 | 8332篇 |
出版年
2023年 | 669篇 |
2022年 | 1567篇 |
2021年 | 3314篇 |
2020年 | 2061篇 |
2019年 | 2908篇 |
2018年 | 4003篇 |
2017年 | 2725篇 |
2016年 | 3164篇 |
2015年 | 3694篇 |
2014年 | 4833篇 |
2013年 | 5996篇 |
2012年 | 7981篇 |
2011年 | 7352篇 |
2010年 | 5133篇 |
2009年 | 4370篇 |
2008年 | 6161篇 |
2007年 | 6302篇 |
2006年 | 5982篇 |
2005年 | 5812篇 |
2004年 | 5105篇 |
2003年 | 4542篇 |
2002年 | 4044篇 |
2001年 | 1585篇 |
2000年 | 1570篇 |
1999年 | 1550篇 |
1998年 | 1010篇 |
1997年 | 884篇 |
1996年 | 729篇 |
1995年 | 598篇 |
1994年 | 528篇 |
1993年 | 484篇 |
1992年 | 739篇 |
1991年 | 706篇 |
1990年 | 680篇 |
1989年 | 603篇 |
1988年 | 615篇 |
1987年 | 508篇 |
1986年 | 502篇 |
1985年 | 507篇 |
1984年 | 428篇 |
1983年 | 318篇 |
1982年 | 297篇 |
1981年 | 224篇 |
1980年 | 210篇 |
1979年 | 270篇 |
1978年 | 184篇 |
1977年 | 205篇 |
1976年 | 184篇 |
1975年 | 171篇 |
1974年 | 187篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
1.
Cromb Amandine Le Loarer Franois Sitbon Maxime Italiano Antoine Stoeckle Eberhard Buy Xavier Kind Michle 《European radiology》2020,30(5):2413-2424
European Radiology - The strongest adverse prognostic factor in myxoid/round cell liposarcomas (MRC-LPS) is the presence of a round cell component above 5% within the tumor bulk. Its identification... 相似文献
2.
3.
4.
Aaron Pitzele Mohammad Rahimi Eric Armbrecht 《The journal of maternal-fetal & neonatal medicine》2015,28(15):1770-1773
Objective: To determine whether packed red blood cell (PRBC) transfusion affects post-prandial superior mesenteric artery blood flow velocities (SMA BFVs) in very-low birth weight (VLBW) neonates and if so, at what time point after transfusion restoration of previous SMA BFV patterns occurs.Design/Methods: VLBW pre-term neonates, older than 14 days and tolerating bolus enteral feedings administered every 3?h were enrolled in this prospective observational study. Pulsed Doppler ultrasound was used to measure pre- and post-prandial (at 45?min) time-averaged mean, peak and end diastolic velocities (TAMV, PSV, EDV) immediately before and after 15?ml/kg of PRBC transfusion was given over 3?h; patent ductus arteriosus (PDA) status was also evaluated. Subsequent pre- and post-prandial SMA BFVs were recorded 24 and 48?h after the transfusion.Results: Pre- and post-prandial measurements were obtained for 21 out of 25 enrolled infants. Post-prandial SMA BFVs were attenuated during the feedings immediately after transfusion; at 24 and 48?h after transfusion, changes in post-prandial SMA BFVs were similar to those measured prior to transfusion; the presence of the PDA did not affect results.Conclusions: PRBC transfusion blunted SMA BFV responses to feedings immediately after the transfusion with normalization observed 24?h post-transfusion. 相似文献
5.
6.
7.
Hui-Ju Ch’ang 《World journal of hepatology》2015,7(16):2029-2040
The success of sorafenib in prolonging survival of patients with hepatocellular carcinoma (HCC) makes therapeutic inhibition of angiogenesis a component of treatment for HCC. To enhance therapeutic efficacy, overcome drug resistance and reduce toxicity, combination of antiangiogenic agents with chemotherapy, radiotherapy or other targeted agents were evaluated. Nevertheless, the use of antiangiogenic therapy remains suboptimal regarding dosage, schedule and duration of therapy. The issue is further complicated by combination antiangiogenesis to other cytotoxic or biologic agents. There is no way to determine which patients are most likely respond to a given form of antiangiogenic therapy. Activation of alternative pathways associated with disease progression in patients undergoing antiangiogenic therapy has also been recognized. There is increasing importance in identifying, validating and standardizing potential response biomarkers for antiangiogenesis therapy for HCC patients. In this review, biomarkers for antiangiogenesis therapy including systemic, circulating, tissue and imaging ones are summarized. The strength and deficit of circulating and imaging biomarkers were further demonstrated by a series of studies in HCC patients receiving radiotherapy with or without thalidomide. 相似文献
8.
9.
Benyam Kinde Harrison W. Gabel Caitlin S. Gilbert Eric C. Griffith Michael E. Greenberg 《Proceedings of the National Academy of Sciences of the United States of America》2015,112(22):6800-6806
DNA methylation at CpG dinucleotides is an important epigenetic regulator common to virtually all mammalian cell types, but recent evidence indicates that during early postnatal development neuronal genomes also accumulate uniquely high levels of two alternative forms of methylation, non-CpG methylation and hydroxymethylation. Here we discuss the distinct landscape of DNA methylation in neurons, how it is established, and how it might affect the binding and function of protein readers of DNA methylation. We review studies of one critical reader of DNA methylation in the brain, the Rett syndrome protein methyl CpG-binding protein 2 (MeCP2), and discuss how differential binding affinity of MeCP2 for non-CpG and hydroxymethylation may affect the function of this methyl-binding protein in the nervous system. 相似文献
10.